Nexalin Technology NXL
NASDAQ NXL
$0.33 +0.00 (+1.45%)
At close: Aug 20, 2026 · 11:57 AM UTC

Nexalin Technology (NXL) Property, Plant & Equipment (Net) Growth (1y) (2022 - 2023)

Nexalin Technology (NXL) Property, Plant & Equipment (Net) Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Abbott Laboratories 200.11 Bn 194.51 Bn 7.27 Bn 12.44%
2 Stryker 129.85 Bn 126.37 Bn 4.50 Bn 6.92%
3 Medtronic 119.93 Bn 110.71 Bn 6.41 Bn 8.48%
4 Boston Scientific 74.18 Bn 73.64 Bn 3.85 Bn 19.21%
5 Edwards Lifesciences 52.54 Bn 48.29 Bn 1.35 Bn 6.67%
6 Dexcom 34.76 Bn 32.81 Bn 830.00 Mn 8.23%
7 GE HealthCare Technologies 34.25 Bn 32.14 Bn 2.18 Bn 6.21%
8 Koninklijke Philips 26.45 Bn 23.13 Bn 4.55 Bn -1.40%
9 Steris 23.29 Bn 22.80 Bn 684.20 Mn 5.69%
10 Nexalin Technology 7.08 Mn 6.07 Mn 8,897.00 -

Historic Data

Download Data
DateValue
Sep 30, 2023 -84.28%
Dec 31, 2022 -51.59%